Status:
TERMINATED
High Flow Oxygen in Patients Undergoing Suspension Laryngoscopy Under General Anesthesia
Lead Sponsor:
CMC Ambroise Paré
Conditions:
Laryngoscopy
Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients undergoing suspension laryngoscopy under general anaesthesia have oxygen delivered to their lungs through different methods. Inserting a tube in the trachea is the best means for oxygen deliv...
Detailed Description
Suspension laryngoscopy is a surgical intervention for which no airway management recommendations exist. Many techniques are used, each having limitations. While tracheal intubation is the gold stand...
Eligibility Criteria
Inclusion
- Consent for participation
- Affiliation to the french social security system
- Patients undergoing any suspension laryngoscopy other than laser surgery and cavoscopy and expected to last less than 30 minutes
Exclusion
- Pregnancy
- Epilepsy
- Arrhythmia
- Pulmonary hypertension
- Lung disease with basal SpO2\<95%
- Obstructive laryngeal tumor
- BMI\>30kg.m-2
Key Trial Info
Start Date :
July 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2019
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03472118
Start Date
July 5 2018
End Date
January 24 2019
Last Update
June 18 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital René Huguenin - Institut Curie
Saint-Cloud, Île-de-France Region, France, 92310
2
Hôpital Foch
Suresnes, Île-de-France Region, France, 92151